Access cutting-edge alcohol use disorder treatment through this clinical trial at a research site in Tulsa. Study-provided care at no cost to qualified participants.
Access alcohol use disorder specialists in Tulsa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alcohol use disorder treatment provided free
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in the treatment of AUD in subjects with obesity or overweight. After signing the informed consent form, subjects will be screened and if eligible randomized 1:1 to 1 of the following 2 treatment arms: * Pemvidutide: 2.4 mg SC once weekly * Placebo: Placebo SC once weekly
Sponsor: Altimmune, Inc.
Check if you qualify for this alcohol use disorder clinical trial in Tulsa, OK
If you're searching for alcohol use disorder treatment options in Tulsa, OK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tulsa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alcohol use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.